Literature DB >> 16099904

Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences.

Erick De la Cruz-Hernández1, Alejandro García-Carrancá1, Alejandro Mohar-Betancourt1, Alfonso Dueñas-González1, Adriana Contreras-Paredes1, Enrique Pérez-Cardenas1, Roberto Herrera-Goepfert2, Marcela Lizano-Soberón1.   

Abstract

Persistent infections of the uterine cervix with 'high-risk' human papillomavirus (HPV) are now recognized as necessary for the development of cervical cancer. Among them, HPV types 16 and 18 exhibit numerous variants associated with different risks for cervical cancer development. In this study, the questions of whether different HPV type 18 variants exhibit changes in early gene transcription and the molecular mechanisms underlying these differences were investigated. It was shown that, indeed, type 18 variants exhibited singular differences in E6 transcripts in vivo. Higher levels of the E6*I transcript were detected regularly in clones harbouring the African variant, as opposed to low levels of this transcript detected in clones containing the reference clone (Asian-Amerindian), where significantly higher levels of full-length E6 transcript were usually observed. As a direct consequence, higher levels of p53 protein were found in the presence of African E6, as opposed to the low levels of p53 observed with the Asian-Amerindian E6. These variations in consequence affected the levels of cellular proteins regulated by p53, such as Bax. Similar changes in the relative levels of E6 transcripts were observed when tumours containing type 18 E6 variants were analysed. The different ability of cells containing variant E6 genes to form tumours in nude mice was suggested by the fact that tumour volumes were considerably higher when cells expressed the Asian-Amerindian E6. Mutagenesis analysis of the reference clone showed that a C491A change reverts the phenotype. These results suggest that different splicing patterns of E6 within HPV type 18 variants may possibly have biological implications in viral tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099904     DOI: 10.1099/vir.0.80945-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  New variants of human papillomavirus type 18 identified in central Brazil.

Authors:  Daniela Marreco Cerqueira; Tainá Raiol; Nazle Mendonça Collaço Véras; Natália von Gal Milanezi; Fádia Aguiar Amaral; Marcelo de Macedo Brígido; Cláudia Renata Fernandes Martins
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

2.  The small splice variant of HPV16 E6, E6, reduces tumor formation in cervical carcinoma xenografts.

Authors:  Maria Filippova; Whitney Evans; Robert Aragon; Valery Filippov; Vonetta M Williams; Linda Hong; Mark E Reeves; Penelope Duerksen-Hughes
Journal:  Virology       Date:  2014-01-01       Impact factor: 3.616

3.  A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter.

Authors:  Chen Gao; Ming-Ming Pan; Yan-Jun Lei; Li-Qing Tian; Hui-Ying Jiang; Xiao-Li Li; Qi Shi; Chan Tian; Yu-Kang Yuan; Gui-Xiang Fan; Xiao-Ping Dong
Journal:  BMC Mol Biol       Date:  2012-02-15       Impact factor: 2.946

4.  Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer.

Authors:  Laura Ortega-Cervantes; Adriana Aguilar-Lemarroy; Aurora Elizabeth Rojas-García; Briscia Socorro Barrón-Vivanco; Verónica Vallejo-Ruiz; David Cantú-De León; Yael Yvette Bernal Hernández; Armando Jáuregui-Martínez; Irma Martha Medina-Díaz
Journal:  Int J Health Sci (Qassim)       Date:  2016-07

5.  Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis.

Authors:  Maria Filippova; Valery A Filippov; Mercy Kagoda; Theodore Garnett; Nadya Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.

Authors:  Alyce A Chen; Tarik Gheit; Silvia Franceschi; Massimo Tommasino; Gary M Clifford
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

7.  Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain.

Authors:  Sonia Pérez; Ana Cid; Amparo Iñarrea; Mónica Pato; María José Lamas; Bárbara Couso; Margarita Gil; María Jesús Alvarez; Sonia Rey; Isabel López-Miragaya; Santiago Melón; María de Oña
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

8.  HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor.

Authors:  J Omar Muñoz-Bello; Leslie Olmedo-Nieva; Leonardo Josué Castro-Muñoz; Joaquín Manzo-Merino; Adriana Contreras-Paredes; Claudia González-Espinosa; Alejandro López-Saavedra; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2018-10-13       Impact factor: 5.923

9.  E6/E7 Functional Differences among Two Natural Human Papillomavirus 18 Variants in Human Keratinocytes.

Authors:  Emily Montosa Nunes; Valéria Talpe-Nunes; João Simão Sobrinho; Silvaneide Ferreira; Vanesca de Souza Lino; Lara Termini; Gabriela Ávila Fernandes Silva; Enrique Boccardo; Luisa Lina Villa; Laura Sichero
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

Review 10.  The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.

Authors:  Leslie Olmedo-Nieva; J Omar Muñoz-Bello; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2018-01-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.